Heart rate variability in people with borderline type personality by Lozovanu, Svetlana et al.
ORIGINAL  ReseARch S. Lozovanu et al. Moldovan Medical Journal. March 2020;63(1):33-38
Introduction
Heart rate variability (HRV) is the time variation of the 
intervals between each heartbeat, recorded as RR intervals 
of the ECG signal. It is a complex physiological phenome-
non that results from the change of heart rate by respiratory, 
circulatory, autonomic, endocrine and mechanical factors. 
Reduced HRV is associated with a variety of conditions such 
as diabetic neuropathy, sepsis, myocardial infarction, but 
lately it has gained increased interest in psychiatry due to 
the connection between autonomic dysfunction and psychi-
atric pathologies [1]. Changes in HRV have been reported in 
many mental disorders [1, 2] as well as correlations of HRV 
with psychological dimensions such as social cognition [2, 
3], interpersonal relations [4, 5] and emotional regulation 
[6, 7] have been described. The increased incidence of car-
diovascular disease associated with psychiatric pathologies 
has also led to increased attention to the autonomic nervous 
system. Borderline personality disorder (BPD) with an in-
creased rate of cardiovascular mortality, and characterized 
by emotional instability, is ideal for studying heart rate vari-
ability. Changes in the heart rate occur due to a constant 
need of the heart to adapt to changing circumstances and it 
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Abstract
Background: Reduced HRV is associated with a variety of conditions such as diabetic neuropathy, sepsis, myocardial infarction, but lately it has gained 
increased interest in psychiatry due to the connection between autonomic dysfunction and psychiatric pathologies. Borderline personality disorder (BPD) 
with an increased rate of cardiovascular mortality, and characterized by emotional instability, is ideal for studying heart rate variability.
Material and methods: 203 subjects were initially evaluated with Personality Inventory for DSM-5, PID-5, (DSM-5 – Diagnostic and Statistical Manual 
of Mental Disorders, 5th edition), and 2 groups have been selected: control group that included 69 subjects and borderline personality disorder (BPD) 
group that included 34 subjects. Heart rate variability (HRV) was analyzed from an electrocardiography signal, recorded in 3 conditions: resting, pain 
stimulation, period following the pain stimulation. 
Results: In post-pain period, in subjects with BPD, the HRV parameters indicate an increase of sympathetic influences on heart rate and a reduction of 
vagal modulatory effects. The values in these subjects did not return to the initial values in the post-pain period as they did in the control group, but, on 
the contrary, the accentuation in the dynamics of the sympathetic influence was registered, even compared to the pain period.
Conclusions: Subjects with BPD presented an increased vagal modulation at rest, which was reduced during pain stimulation and did not return rapidly 
to the initial value after removing the painful stimulus, which can be proof of the inertia of autonomic influences in these subjects.
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is believed that the loss of balance between the sympathetic 
and parasympathetic nervous system causes alteration of 
the HRV structure [8]. In this context, HRV is a measure of 
autonomic nervous system balance, and therefore may pro-
vide a quantification of the physiological changes associated 
with mental illness.
In the last two decades since the first studies appeared 
and until now, multiple connections between resting heart 
rate variability and psychological functions, including psy-
chopathological expression, have been described. In gen-
eral, these early studies, and many of those that appeared 
afterwards, showed that HRV correlates with various adap-
tive psychological effects among children, adolescents, and 
adults, including the empathic response to other sufferings 
[9, 10], social competence [5], ability to hold attention for 
a long time [11], cognitive performance [12], adjustments 
behavior during social challenges and positive interactions 
with partners [13]. Low HRV at rest, or a large reduction as-
sociated with various challenges (particularly emotions) are 
associated with symptoms of both introverted and extro-
verted psychopathology [6, 14-16], with a broad spectrum 
of psychopathological syndromes, including anxiety [12, 
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17], phobias [14], attention deficit [18], emotional insensi-
tivity [6, 8, 18], behavior disorder [14, 15], depression [17], 
non-suicidal self-injury [17, 19], panic attacks [5, 7,  17]), 
hostility [12, 17, 19], psychopathy [12], schizophrenia and 
others. In addition, internalizing or externalizing comorbid 
symptoms predict an additional reduction in cardiac vari-
ability during emotional challenges than internalizing or 
externalizing symptoms of a self-esteem [17]. This impres-
sive long list suggests that HRV at rest and low reactivity 
to emotional challenges mark one or more essential self-
regulatory functions that are disturbed by various forms of 
psychopathologies. Understanding the neural bases of HRV, 
and determining the neural bases that give rise to plastic-
ity phenomena, can therefore have important treatment 
implications, and is a key moment in the path to modify-
ing circuits to reduce the adverse effects on mental health in 
vulnerable individuals.
BPD is characterized by personality traits in the field of 
negative affectivity, emotional lability, anxiety, separation 
insecurity or depression and behavioral characteristics such 
as disinhibition (including impulsivity and risk-taking) or 
antagonism (hostility) [20].
This represents a pervasive pattern characterized by in-
stability in interpersonal relationships, self-image and affec-
tivity, as well as by increased impulsivity, which begins at 
the young adult age, manifests through identity disorders, 
recurrent suicidal behavior, irritability or anxiety, sustained 
efforts to avoid a real or imaginary abandonment, chronic 
feeling of inner emptiness etc. The median prevalence in the 
population of BPD was estimated at 1.6%, but may reach 
5.9%. Taking into account the increased prevalence of BPD 
of 6% in primary health care and up to 20% in specialized 
psychiatry centers [21] and the considerable deficiencies 
caused to patients, the study of heart rate variability could 
offer to physicians, especially those at primary level, an al-
ternative to pharmacological treatment, by correcting the 
psychophysiological mechanisms that lead to the appear-
ance of systemic dysfunctions.
 Genetic researches on BPD have mainly focused on 
genes involved in serotoninergic and dopaminergic systems. 
Tryptophan hydroxylase is an enzyme involved in the 5-HT 
synthesis of the tryptophan amino acid. Most studies have 
shown that two isoforms of tryptophan hydroxylase (TPH-1 
and TPH-2) are associated with BPD [22]. Serotonin trans-
porter genes (5-HTT), especially 5-HTTLPR (serotonin-
transporter-linked polymorphic region}, are associated with 
BPD, depressive, anxious and obsessive-compulsive traits, 
but not with suicidal or self-destructive behaviors. On the 
other hand, monoamine oxidase A (MAO-A), an enzyme 
that degrades monoamines, especially serotonin, is involved 
after its recovery from the synaptic cleft. It has been shown 
that patients with BPD have a variable number of MAO-
A gene repeats different from healthy volunteers [22, 23]. 
The brain-derived neurotrophic factor (BDNF) involved in 
neurogenesis, synaptogenesis and regulation of serotonin 
metabolism, the BDNF Val66Val polymorphism could also 
play a role in the pathogenesis of BPD [24].
The main features of each personality disorder (PD) are 
emotional disorders that may manifest themselves in differ-
ent ways, but nonetheless, they are rooted in neural orga-
nization. For example, emotional instability is a basic pat-
tern observed in BPD. Other features of this disorder are 
the tendency toward suicide, outbursts of intense anger, 
stormy relationships and identity disorders [19]. All these 
patterns are related to increased attention or sensitivity to 
social-emotional indices in interpersonal scenarios, the ten-
dency towards self-referential emotional processing and the 
mechanisms of unregulated emotional processing. Patients 
with BPD have great difficulty in moving from the psychic 
equivalence mode to the pretending mode and often retain 
their perception as an absolute fact [25].
Studies involving mental health and investigating differ-
ences in heart rate variability use numerous time, frequency, 
or non-linear methods that quantify HRV [15, 26-31].
However, there are no widely recognized standards for 
measuring and quantifying heart rate variability and the 
clinical interpretation of many features of variability re-
mains contradictory or unknown. Studies involving the 
analysis of heart rate variability in mental pathologies have 
minimal standardization [27, 32-35] especially regarding 
the analysis of time intervals and the methods of recording 
ECG, making comparing the results of variability over dif-
ferent time intervals additionally difficult. The variations in 
the duration of the recordings, the degree of activity of the 
participants and the methods of data collection may be dif-
ferent. For example, data is usually collected when the par-
ticipant is at rest; however, the participant’s posture, time of 
day, recent consumption of food or drink and many other 
factors may contribute to heart rate variability. Stimuli in 
the form of pictures or exercises can be exposed during re-
cordings, making comparison between studies difficult.
The purpose of the study is to determine the autonomic 
changes in people with borderline personality disorder by 
studying the variability of the heart rate both at rest and in 
the pain test.
Material and methods
The current study was designed to determine autonomic 
changes in people with borderline personality disorder by 
studying heart rate variability under the influence of painful 
stimuli.
203 subjects were initially evaluated, between March 
2017 – February 2020, in Nicolae Testemitsanu State Uni-
versity of Medicine and Pharmacy at the Department of 
Human Physiology and Biophysics. All subjects had signed 
an informed agreement. The exclusion criteria were: acute 
or chronic cardiac diseases; medications that could influ-
ence heart rhythm variability. The psychometric evalua-
tion, which preceded the recording of cardiac parameters, 
was performed using the Personality Inventory for DSM-
5, PID-5 (DSM-5 – Diagnostic and Statistical Manual of 
Mental Disorders, 5th edition) [36], which is a tool for self-
assessment of personality traits, developed by the Ameri-
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can Psychiatric Association (AAP) in 2012. PID-5 has been 
translated into Romanian and validated by a working group 
consisting of the staff of Nicolae Testemitsanu State Uni-
versity of Medicine and Pharmacy and the Department of 
Headache and Vegetative Disorders within the Institute of 
Neurology and Neurosurgery, in compliance with the rules 
of translation, adaptation and validation of the International 
Test Commission and with the consent of the authors. PID-
5 is a questionnaire, containing 220 personality self-report 
items, used to measure maladaptive personality traits, 
which are characterized in DSM-5. The answers are selected 
from a four-point scale, from 0 (“very false or often false”) 
to 3 (“very true or often true”). Thus, PID-5 offers scores 
evaluated on a scale of 4 points, for the 25 facets. Each facet 
includes from 4 to 14 elements. These facets correspond to 
the maladaptive personality traits described in section III of 
the DSM-5 and are included in the five areas of higher or-
der, also described in section III: negative affect, separation, 
antipathy, disinhibition and psychosis. The score greater 
than 2 in a certain number of facets is a quantitative index 
of one of the 6 types of PD: Antisocial, Borderline, Schizo-
typal, Avoidant, Obsessive-Compulsive or Narcissistic [20, 
37, 38]. 
Fig. 1. Subject with Borderline personality disorder, with 
numerical scores greater than 2 in 4 facets.
Note: for the borderline personality disorder the distribution of the 
numerical scores of 7 facets is studied. For a positive result, it is necessary 
that 4 of the 7 facets to have scores greater than 2 on the axis of the 
ordinates.
 Finally, based on the obtained results in the PID-5, the 
examined subjects were distributed in 2 groups, according 
to the number of the numeric scores greater than 2 in 4 out 
of 7 personality traits characteristic for the borderline per-
sonality disorder: Anxiety, Depression, Emotional Lability, 
Hostility, Impulsivity, Risk taking, Separation insecurity:
– First group – PID traits with all numerical score in the 
range 0-1.99, healthy people (control group);
– Second group – PID: 4 features out of 7 with numerical 
score more than 2.0, of which at least one to be an obligatory 
trait (marked in bold) (BPD group).
Subjects with numerical score greater than 2.0 in 1-3 
facets of BPD were not included in the study. The BPD pro-
file of a person who was included in the study shows that 4 
of the 7 facets have a numeric score greater than 2 (fig. 1). 
The age of the people included in the study was between 18 
and 60 years. The groups were homogeneously distributed 
according to sex, namely 53 women (mean age 41 years) 
and 49 men (mean age 39 years). Control group included 
69 subjects (N = 69) with a mean age of 40 years (35 wom-
en and 33 men) and BPD group included 34 subjects (N = 
34) with a mean age of 36 years (18 women and 16 men) 
(fig. 2, 3).
Fig. 2. Distribution of participants according to gender and age.   
         
Fig. 3. Distribution of Control subjects and Borderline subjects 
according to age.
All studies were performed in the morning (08:00-10:00 
AM) without the person’s consuming any food that morn-
ing, in lying position. The experimental protocol included 
the recording of electrocardiogram in the standard II lead 
during 3 periods: 
1. Breathing at rest (resting period) – in physical, mental 
and emotional resting conditions, 5 min;
2. Pain test (pain stimulation) – painful stimulus, the 
cuff of the sphygmomanometer at a constant pressure of 200 
mm Hg was applied at the level of the left arm of the subject, 
for 5 min;
3. Post-pain period – the pressure was removed and re-
cording continued for another 5 min.
 The experimental protocol included the recording of 
ECG in subjects in lying position, in a quiet room, with 
moderate light, at comfort temperature. During the record-
ing, the subjects were asked to breathe quietly, not to speak 
and to avoid additional movements.
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The ECG signal was recorded using the system Biopac 
MP-100. The processing of the data was performed with 
the software “Kubios HRV Standard” (version 3.2.0, 2019), 
manually removing the artifacts.
The spectral analysis Fourier of the RR interval (NN) 
variation included the total spectral power TSP (ms2) and 
calculation of the spectral components: very low frequen-
cy (VLF) – less than 0.04 Hz (ms2), low frequency (LF) – 
between 0.04 and 0.15 Hz (ms2) and high frequency (HF) 
– more than 0.15 Hz (ms2). The normalized components 
LFnu and HFnu were calculated by division of power of 
components HF (ms2) and LF (ms2) by the total spectral 
power without VLF (ms2) [32].  LF is often considered as an 
index of sympathetic modulation, and the HF component is 
used to evaluate the vagal activity.  Following time domain 
parameters of the HRV were determined:
RMSSD – Root Mean Square of the Successive Differ-
ences in neighboring NN intervals (ms);
SDNN – the Standard Deviation of NN intervals during 
studied period (ms); 
 NN50 – the number of pairs of successive NNs that dif-
fer by more than 50 ms;
pNN50 – pNN50, the proportion of NN50 divided by 
total number of NNs.
The statistical analysis was performed using IBM SPSS 
Statistics 23.0 software, t-Student test was used to compare 
the HRV values inside the groups and between the groups. 
Results and discussions
The data about HRV in people with BPD compared to 
healthy people presented in a review that analyzed HRV in 
mood disorders, including BPD, in the papers published 
between 1980 and May 2017 and found in PubMed, Psy-
cINFO, Google Scholar and the Cochrane Library [33] are 
highly controversial. Our study confirms the heterogene-
ity of the results obtained by the HRV analysis between the 
people with BPD and healthy at rest as well as during pain 
test and after it.
HRV parameters of the time domain method (NN50, 
pNN50, SDNN and RMSSD) as well as LFnu and HFnu 
did not show significant differences between the groups in-
cluded in the study at rest. In the pain test, the differences 
have been found between the parameters in the frequency 
domain of the HRV, namely LFnu is 13.9% lower in the BPD 
group (50.30 ± 3.60) compared to the control group (58.42 ± 
2.37), p <0.05; (fig. 4) and respectively HFnu is 19.4% higher 
in the BPD group (49.45 ± 3.58) compared to the control 
group (41.39 ± 2.36), p <0.05; (fig. 5).
The veracity of the comparative differences between the 
functional tests was more evident within the study groups. 
In the group with BPD the pain caused a decrease of RMS-
SD by 10% (44.23 ±10.2 compared to 49.26 ± 10.95 at rest), 
p <0.05; other changes were not detected (tab. 1).
Fig. 4. LFnu values in subjects in control group and BPD group.
Fig. 5.  HFnu values in subjects in control group and BPD group.
Table 1
HRV parameters in control and BPD groups
    Test 
HRV
Study groups
Control group (N=69) BPD group (N=36)
Resting Pain Post-pain Resting Pain Post-pain
RR (NN) (ms) 875.67 ± 18.4 868.84 ± 17.65 878.90 ± 16.80∆ 825.61 ± 24.53 828.05 ± 25.24 830.62 ± 22.71
SDNN (ms) 50.23 ± 5.17 49.13 ± 4.14 53.29 ± 4.34∆ 54.51 ± 7.02 50.29 ± 6.45 59.16 ± 6.42 ∆∆∆    
RMSSD (ms) 46.18 ± 5.99 42.84 ± 5.06 45.34 ± 5.39 49.26 ± 10.95 44.23 ± 10.2* 50.88 ± 10.1 ∆∆
pNN50 16.46 ± 2.76 16.42 ± 2.65 17.84 ± 2.71 16.92 ± 3.36 16.73 ± 3.45 19.41 ± 3.67 Ø  ∆
LF/HF 1.64 ± 0.24 2.10 ± 0.25 1.65 ± 0.27 1.56 ± 0.28 1.63 ± 0.33 2.06 ± 0.35 
LFnu 51.35 ± 2.56 58.42 ± 2.37** 52.54 ± 2.38∆ 48.62 ± 3.99 50.30 ± 3.60 56.58 ± 3.38 Ø Ø ∆    
HFn 48.44 ± 2.55 41.39 ± 2.36** 47.36 ± 2.38∆∆ 51.22 ± 3.97 49.45 ± 3.58 43.28 ± 3.37 Ø Ø  ∆
Statistical differences between values within study groups. Resting /Pain: *– p<0.05; **–p<0.01; *** p<0.001. Resting/Post-pain: Ø – p<0.05; 
Ø Ø –p<0.0 Ø Ø Ø   p<0.001. Pain/Post-pain: ∆ – p<0.05; ∆∆∆  –p<0.0∆∆∆   p<0.001.
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In contrast, after the removal of the painful stimulus, 
statistically significant differences in several time domain 
parameters of the HRV are observed in post-pain period 
versus pain stimulation and resting in the BPD group. 
pNN50 was 14.7% higher in the post-pain period (19.41 ± 
3.67) than at rest (16.92 ± 3.37), p <0.05; SDNN – was 18% 
higher post-pain (59.16 ± 6.42) compared to (50.29 ± 6.45) 
during pain, p <0.001; and RMSSD was with 15% higher 
during post-pain period (50.88 ± 10.1) than during pain 
stimulation (44.23 ± 10.2), p <0.01 (tab. 1).
The components of the spectral analysis Fourier, LFnu 
and HFn, were different in post-pain period in compari-
son with resting and pain test. We reported an increase of 
LFnu by 16.3% in BPD group in post-pain (56.58 ± 3.39) 
compared to rest (48.62 ± 3.99), p <0.01, and by 12% in 
post-pain (56.58 ± 3.38) compared to pain period (50.30 ± 
3.60), p <0.05, which indicates an increase in activity pf the 
sympathetic autonomic nervous system. HFnu was 15.5% 
lower in post-pain (43.28 ± 3.37) than at rest (51.22 ± 3.97), 
p <0.01; and by 13% lower in post-pain (43.28 ± 3.37) than 
in pain period (49.45 ± 3.58), p <0.05.
The time domain parameters: RR (NN), SDNN, RMSSD, 
pNN50 within the control group did not show significant 
changes in both pain stimulation and post-pain period 
compared to rest.
During pain stimulation in the control group, we could 
see statistically significant differences between the LFnu and 
HFnu values compared to rest: LFnu was 14% higher during 
pain (58.42± 2.37) than in resting period (51.35 ± 2.56), p 
<0.01; HFnu was 15% lower during pain (41.39 ± 2.36) than 
in resting period (48.44 ± 2.55), p <0.01 (tab. 1).
In the control group the pain stimulation produced sta-
tistical changes in LFnu and HFn, and in the BPD group the 
pain stimulation did not produce statistically valid changes, 
which speaks about a delayed activation of the autonomic 
nervous system in subjects with BPD.
During post-pain period in the control group, we ob-
served statistically significant changes in the HRV; the av-
erage duration of the RR interval increases by 1% in post-
pain period (878.90 ± 16.80) compared to pain stimulation 
(868.84 ± 17.65), p <0.05; SDNN was increased by 8% in 
post-pain period (53.29 ± 4.34) in comparison with pain 
stimulation (49.13 ± 4.14), p <0.05.
HFnu was by 14% higher during post-pain period (47.36 
± 2.38) compared to pain stimulation (41.39 ± 2.36), p <0.01; 
LFnu was decreased by 10% in post-pain period (52.54 ± 
2.38) compared to pain stimulation (58.42 ± 2.37), p <0.05.
In subjects with BPD, higher HFnu values are observed 
at rest, marking an accentuated vagal modulation of the 
heart rhythm, and a lower sympathetic influence on the 
heart rhythm.
During the pain stimulation, a decrease of the vagal 
activity and an increase of the sympathetic activity on the 
heart rate were observed in both groups.
In post-pain period, LFnu and HFnu values in subjects 
with BPD were reversed compared to resting period, which 
indicates an increase of sympathetic influences on heart rate 
and a reduction of vagal modulatory effects. The LFnu and 
HFnu values in these subjects did not return to the initial 
values in the post-pain period as they did in the control 
group, but, on the contrary, the accentuation in the dynam-
ics of the sympathetic influence was registered, even com-
pared to the pain period.
Conclusions
1. The results regarding HRV in subjects with BPD, 
obtained in this study, are in concordance with the results 
of the studies in the research papers regarding the increased 
vagal modulation in subjects with BPD at rest, which is 
reduced during pain stimulation and does not return 
rapidly to the initial value after removing the painful 
stimulus, which can be the proof of the inertia of autonomic 
influences in these subjects.
2. Selecting the subjects for the study with the help of 
PID-5, translated and adapted for Romanian speakers in the 
Republic of Moldova, showed that PID-5 is a valid and useful 
tool for studying HRV in people with personality disorders.
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